Opposing findings employing Arg2-deficient mice have shown that Arg2-deficiency results in development of spontaneous hepatic steatosis and increased liver injury (142) or promotes decreased NAFLD severity in obesity (143). Here, ARG2 is linked to metabolic dysfunction-associated steatotic liver disease.